Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion description "[Furthermore, several central and peripheral nervous system tumors express CRF receptors: medulloblastomas, paragangliomas, neuroblastomas, and some meningiomas express CRF(1) receptors, but ependymomas or Ewing sarcomas do not.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion evidence source_evidence_literature NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion SIO_000772 12843181 NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion wasDerivedFrom befree-20150227 NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_assertion wasGeneratedBy ECO_0000203 NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.
- befree-20150227 importedOn "2015-02-27" NP326301.RARZUuXQYCnw9_NcO-4wtpSNhNorO-kegdSGoT1o6k0rM130_provenance.